VSee Health entered into a securities purchase agreement with Labrys for a $336,000 unsecured convertible promissory note, including a $36,000 original issue discount. The note carries a one-time 12% interest charge and matures on June 30, 2027, with optional prepayment within 181 days and a procee…
HOUSTON, TX / ACCESS Newswire / July 28, 2026 / VSee Health, Inc. NASDAQ:VSEE ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today announced that its Board of Directors has initiated a comprehensive strategic review aimed at pursuing transformational oppor…
VSee Health entered a comprehensive settlement with ADI Funding and M2B Funding to resolve disputes tied to an ADI-secured note and ELOC-related obligations. The agreement sets a structured repayment plan, including repayment of the existing ADI note within 90 days or upon receipt of financing proc…
VSEE's Telehealth Platform is Positioned at the Center of Healthcare's AI TransformationHOUSTON, TX / ACCESS Newswire / July 14, 2026 / VSee Health, Inc. NASDAQ:VSEE ("VSee" or the "Company"), a leading provider of enterprise telehealth solutions for hospitals and health systems, today shared its s…
HOUSTON, TX / ACCESS Newswire / July 9, 2026 / VSee Health, Inc. NASDAQ:VSEE ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, today issued the following letter from Chairman and Chief Executive Officer Dr. Imoigele Aisiku providing shareholders with an updat…
